Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, et al.
Journal of Intensive Care Medicine (2021) Vol. 37, Iss. 4, pp. 491-499
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure
Lila Bouadma, Armand Mekontso Dessap, Charles Burdet, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 9, pp. 906-906
Open Access | Times Cited: 103
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2022) Vol. 2022, Iss. 11
Open Access | Times Cited: 47
Resolution pharmacology and the treatment of infectious diseases
Vivian Vasconcelos Costa, Filipe Resende, Eliza Mathias Melo, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 7, pp. 917-937
Open Access | Times Cited: 7
Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial
Huimin Wu, Salim Daouk, Jad Kebbe, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0275217-e0275217
Open Access | Times Cited: 34
Glucocorticoids and COVID-19
Stefano Bruscoli, Pier Giorgio Puzzovio, Maria Zaimi, et al.
Pharmacological Research (2022) Vol. 185, pp. 106511-106511
Open Access | Times Cited: 27
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Corticosteroids in COVID-19: pros and cons
Aymen Bahsoun, Yeva Fakih, Rana Zareef, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103080-103080
Closed Access
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia
Anders Granholm, Maj-Brit N. Kjær, Marie Warrer Munch, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 5, pp. 580-589
Open Access | Times Cited: 25
Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce
Zachary Willis, Carlos R. Oliveira, Mark J. Abzug, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 3, pp. 159-185
Open Access | Times Cited: 4
Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts
Y. Zhao, Zhun Yao, Song Xu, et al.
Journal of Intensive Medicine (2024) Vol. 4, Iss. 4, pp. 417-432
Open Access | Times Cited: 4
Dosage and utilization of dexamethasone in the management of COVID-19: A critical review
Imran Sethi, Asim Shaikh, Musa Sethi, et al.
World Journal of Virology (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 4
Glucocorticoid Therapy in COVID-19
Francesco Amati, Antonio Tonutti, John C. Huston, et al.
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 01, pp. 100-117
Closed Access | Times Cited: 9
Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID‐19 pneumonia: An open‐label randomised trial
Luís Corral-Gudino, Iván Cusacovich, José Ignacio Martín‐González, et al.
European Journal of Clinical Investigation (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 15
An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8
Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs
Xiangrong Ye, Li Ye, Feng Luo, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The Multifaceted Role of Annexin A1 in Viral Infections
Filipe Resende, Simone de Araújo, Luciana P. Tavares, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1131-1131
Open Access | Times Cited: 7
Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis
Timothy Arthur Chandos Snow, Nishkantha Arulkumaran, Mervyn Singer, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 490-497
Closed Access | Times Cited: 6
Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles
Anthony D. Bai, Yunbo Jiang, David Nguyen, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2253301-e2253301
Open Access | Times Cited: 5
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter—A Critical Review and Viewpoints
Francesco Salton, Paola Confalonieri, G. Umberto Meduri, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 924-924
Open Access | Times Cited: 5
Efficacy and safety of glucocorticoids use in patients with COVID-19: a systematic review and network meta‑analysis
Qiaolan He, Chen Wang, Yingqin Wang, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial
Graciela Cárdenas, María Chávez‐Canales, Ana Marı́a Espinosa, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 2, pp. 102960-102960
Closed Access | Times Cited: 1
High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study
Raeseok Lee, Sung‐Yeon Cho, Dong‐Gun Lee, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 34
Open Access | Times Cited: 1
Associations between corticosteroid dosage and clinical outcomes in patients with hypoxemic COVID-19 pneumonia: A retrospective cohort study
Napassorn Teeratakulpisarn, Supattra Chiewroongroj, Thummaporn Naorungroj, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308069-e0308069
Open Access | Times Cited: 1
The impact of dexamethasone on short- and long-term mortality in hospitalized COVID-19 patients: a retrospective study
Jianping Zhao, Hongyang Jiang, Huyun Wan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top